Titulo:

Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
.

Sumario:

.

Guardado en:

2256-2877

2256-2915

2

2013-07-01

41

44

Diego Aguirre - 2013

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

info:eu-repo/semantics/openAccess

http://purl.org/coar/access_right/c_abf2

id metarevistapublica_acho_revistacolombianadehematologiayoncologia_27_article_343
record_format ojs
spelling Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
Right atrial appendage resembling residual tumor in mesothelioma treated with extrapleural pneumonectomy, chemotherapy and IGRT.
.
Aguirre, Diego
Bernal, Laura
Carranza, Hernán
Vargas, Carlos
García Herreros, Luis Gerardo
Otero, Jorge Miguel
Ucrós, Gonzalo
Bernal, Patricia
Cardona, Andrés Felipe
2
2
Núm. 2 , Año 2013 : Julio
Artículo de revista
Journal article
2013-07-01T00:00:00Z
2013-07-01T00:00:00Z
2013-07-01
application/pdf
Asociación Colombiana de Hematología y Oncología (ACHO)
Revista Colombiana de Hematología y Oncología
2256-2877
2256-2915
https://revista.acho.info/index.php/acho/article/view/343
10.51643/22562915.343
https://doi.org/10.51643/22562915.343
spa
https://creativecommons.org/licenses/by-nc-sa/4.0
Diego Aguirre - 2013
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
41
44
Yanagawa J, Rusch V. Surgical management of malignant pleural mesothelioma. Thorac Surg Clin [online] 2013 [cited 2013 Jun 19];23(1):73-87, vi.
Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg [online] 2009 [cited 2013 Jun 19];21(2):172-6.
Baldini EH, Recht A, Strauss GM, DeCamp MM Jr, Swanson SJ, Liptay MJ, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg [online] 1997;63(2):334-8.
Gerbaudo VH, Katz SI, Nowak AK, Francis RJ. Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging. PET Clin. 2011;6(3):275-97.
Nguyen BD. PET/CT Demonstration and Monitoring of Thoracic and Abdominal Wall Mesothelioma. Clin Nucl Med. 2013;1-4.
Zahid I, Sharif S, Routledge T, Scarci M. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg. 2011;12(2):254-9.
Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41(1):1-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11750145.
Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21(2):111-20.
Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol. 2007;64(3):356-66.
Orcajo Rincón J, Alonso Farto JC, Rotger Regi A, Hernández Pérez R, Hualde AM, Pérez Aradas V. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy. Rev Esp Med Nucl. 2011;30(5):307-10.
Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20(2):215-20.
Fuccio C, Spinapolice EG, Ferretti A, Castellucci P, Marzola MC, Trifirò G, et al. (18)F-FDG-PET/CT in malignant mesothelioma. Biomed Pharmacother. 2013;8-11.
Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18Ffluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
Sterman DH, Albelda SM. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology. 2005;10(3):266-83.
Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl med. 2007;48(10):1662-9.
Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31(5):1287-305.
Zöphel K, Kotzerke J. High intraindividual variability of global myocardial 18F-FDG uptake over time. J Nucl Med. 2008;49(9):1570.
Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, et al. PET/CT quantitation of the effect of patientrelated factors on cardiac 18F-FDG uptake. J Nucl Med. 2007;48(2):234-9.
Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, et al. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thor Oncol. 2009;4(12):1480-4.
https://revista.acho.info/index.php/acho/article/download/343/305
info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
http://purl.org/redcol/resource_type/ARTREF
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Text
Publication
institution ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png
country_str Colombia
collection Revista Colombiana de Hematología y Oncología
title Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
spellingShingle Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
Aguirre, Diego
Bernal, Laura
Carranza, Hernán
Vargas, Carlos
García Herreros, Luis Gerardo
Otero, Jorge Miguel
Ucrós, Gonzalo
Bernal, Patricia
Cardona, Andrés Felipe
title_short Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
title_full Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
title_fullStr Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
title_full_unstemmed Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
title_sort auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e igrt.
title_eng Right atrial appendage resembling residual tumor in mesothelioma treated with extrapleural pneumonectomy, chemotherapy and IGRT.
description .
author Aguirre, Diego
Bernal, Laura
Carranza, Hernán
Vargas, Carlos
García Herreros, Luis Gerardo
Otero, Jorge Miguel
Ucrós, Gonzalo
Bernal, Patricia
Cardona, Andrés Felipe
author_facet Aguirre, Diego
Bernal, Laura
Carranza, Hernán
Vargas, Carlos
García Herreros, Luis Gerardo
Otero, Jorge Miguel
Ucrós, Gonzalo
Bernal, Patricia
Cardona, Andrés Felipe
citationvolume 2
citationissue 2
citationedition Núm. 2 , Año 2013 : Julio
publisher Asociación Colombiana de Hematología y Oncología (ACHO)
ispartofjournal Revista Colombiana de Hematología y Oncología
source https://revista.acho.info/index.php/acho/article/view/343
language spa
format Article
rights https://creativecommons.org/licenses/by-nc-sa/4.0
Diego Aguirre - 2013
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
references Yanagawa J, Rusch V. Surgical management of malignant pleural mesothelioma. Thorac Surg Clin [online] 2013 [cited 2013 Jun 19];23(1):73-87, vi.
Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg [online] 2009 [cited 2013 Jun 19];21(2):172-6.
Baldini EH, Recht A, Strauss GM, DeCamp MM Jr, Swanson SJ, Liptay MJ, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg [online] 1997;63(2):334-8.
Gerbaudo VH, Katz SI, Nowak AK, Francis RJ. Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging. PET Clin. 2011;6(3):275-97.
Nguyen BD. PET/CT Demonstration and Monitoring of Thoracic and Abdominal Wall Mesothelioma. Clin Nucl Med. 2013;1-4.
Zahid I, Sharif S, Routledge T, Scarci M. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg. 2011;12(2):254-9.
Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41(1):1-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11750145.
Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21(2):111-20.
Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol. 2007;64(3):356-66.
Orcajo Rincón J, Alonso Farto JC, Rotger Regi A, Hernández Pérez R, Hualde AM, Pérez Aradas V. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy. Rev Esp Med Nucl. 2011;30(5):307-10.
Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20(2):215-20.
Fuccio C, Spinapolice EG, Ferretti A, Castellucci P, Marzola MC, Trifirò G, et al. (18)F-FDG-PET/CT in malignant mesothelioma. Biomed Pharmacother. 2013;8-11.
Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18Ffluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
Sterman DH, Albelda SM. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology. 2005;10(3):266-83.
Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl med. 2007;48(10):1662-9.
Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31(5):1287-305.
Zöphel K, Kotzerke J. High intraindividual variability of global myocardial 18F-FDG uptake over time. J Nucl Med. 2008;49(9):1570.
Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, et al. PET/CT quantitation of the effect of patientrelated factors on cardiac 18F-FDG uptake. J Nucl Med. 2007;48(2):234-9.
Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, et al. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thor Oncol. 2009;4(12):1480-4.
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2013-07-01
date_accessioned 2013-07-01T00:00:00Z
date_available 2013-07-01T00:00:00Z
url https://revista.acho.info/index.php/acho/article/view/343
url_doi https://doi.org/10.51643/22562915.343
issn 2256-2877
eissn 2256-2915
doi 10.51643/22562915.343
citationstartpage 41
citationendpage 44
url2_str_mv https://revista.acho.info/index.php/acho/article/download/343/305
_version_ 1811200923946450944